Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Hodgkin Disease × Injections × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Advanced Solid Tumor 13 Leukemia, Myeloid, Acute 10 Breast Neoplasms 6 Solid Tumor 5 Pancreatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 4 Advanced Solid Tumors 4 Neoplasm Metastasis 3 Myelodysplastic Syndromes 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Biliary Tract Neoplasms 3 Advanced Malignant Solid Tumor 3 Advanced Lung Cancer 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Solid Tumors 2 Small Cell Lung Carcinoma 2 Recurrence 2 Prostatic Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Liver Neoplasms 2

Interventions

Cyclophosphamide 17 Etoposide 16 fludarabine phosphate 15 Peripheral Blood Stem Cell Transplantation 14 Rituximab 13 Brentuximab Vedotin 13 fludarabine 11 Whole-Body Irradiation 10 Nivolumab 10 Mycophenolic Acid 10 Melphalan 10 Tacrolimus 9 Filgrastim 9 Bendamustine Hydrochloride 9 Carboplatin 8 Ifosfamide 7 Gemcitabine 7 Cytarabine 7 Cyclosporine 7 Busulfan 7 Doxorubicin 6 Prednisone 5 Everolimus 5 Antilymphocyte Serum 5 pembrolizumab 4 Vinblastine 4 Methotrexate 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Carmustine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03343665 2020-01-23

Nivo40

St. Petersburg State Pavlov Medical University

Phase 1/2 Completed

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡